Microelectronic Medical Implants: Products, Technologies & Opportunities

Report Code: HLC016F

Publish Date: Jul 2024

Publisher: BCC Publishing

Category: Health Maintenance

Download Report Overview

Single User License: $4650

Member Price: FREE

EXPLORE OFFERS

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global market for microelectronic medical implants is expected to grow from $49.0 billion in 2024 and is projected to reach $85.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.7% during the forecast period of 2024 to 2029. 

Report Includes

  • 64 data tables and 30 additional tables
  • An overview of the global market for microelectronic medical implants
  • Analysis of global market trends, featuring historical revenue data for 2021-2023, estimated figures for 2024, forecasts for 2029, and projected CAGRs through 2029
  • Evaluation of the current market size and revenue growth prospects, along with market share analysis by product type, application, and geographic region
  • Discussion of innovations, technological advances, and product launches
  • Analysis of the industry’s regulatory framework and policies
  • A look at the product pipeline
  • Discussion of ESG practices of companies in the industry, and the ESG challenges facing them
  • Analysis of the leading companies’ market shares, proprietary technologies, and strategic alliances
  • Evaluation of key patents
  • Profiles of the leading players, including Abbott, Cochlear Ltd., LivaNova PLC, Medtronic, and NEVRO CORP.

Report Scope

This report analyzes the trends in the global and regional markets for microelectronic medical implants with data from 2023, estimates from 2024, and projections of compound annual growth rates (CAGRs) for the forecast period of 2024 to 2029. This report also analyzes the competitive environment, including the market shares of leading companies, the regulatory scenario, and the drivers, restraints and opportunities in the market.

The market in this report is segmented into product types and applications. Product types include pacemakers, defibrillators, neurostimulators, hearing implants, ocular implants, and others. Applications includes cardiology, neurology, audiology, ophthalmology, and others.

The market is segmented into four regions: North America, Europe, Asia-Pacific and Rest of the World (RoW). The regional analysis include coverage of the markets in the U.S., Germany, the U.K., France, Japan, China, and India. The market value is estimated for 2023, with forecasts for 2024 and 2029.

The report’s goals are to:

  • Analyze main implant types and applications.
  • Analyze global market size and segmentation.
  • Understand market constraints and drivers.
  • Provide detailed market forecasts up to 2029.
  • Assess market shares, competitiveness, and industry structure.
  • Identify potential long-term impacts on the microelectronic implants industry

Report Synopsis

Report Metrics Details
Base year considered 2023
Forecast period considered 2024-2029
Base year market size $44.1 billion
Market size forecast $85.1 billion
Growth rate CAGR of 11.7% for the forecast period of 2024-2029
Units considered $ Millions
Segments covered Product Type, Application, and Region
Regions covered North America, Europe, Asia-Pacific, and Rest of the World (RoW)
Countries covered China, India, Japan, U.S., Canada, Mexico, Germany, U.K., Italy, and France
Key Market Drivers
  • Increasing incidence of atrial fibrillation
  • More potential applications for microelectronic medical implants
  • Increasing use of these implants
  • Technological advances in these implants
  • The world’s growing number of elderly
Companies studied
ABBOTTBIOTRONIK
BOSTON SCIENTIFIC CORP.COCHLEAR LTD.
INSPIRE MEDICAL SYSTEMS INC. LIVANOVA PLC
MEDTRONIC MICROPORT SCIENTIFIC CORP.
NEUROPACE INC. NEVRO CORP.
Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW

Frequently Asked Questions (FAQs)

The global market for microelectronic medical implants was valued at $44.1 billion in 2023 and is projected to reach $85.1 billion by the end of 2029.
The growth of the global market is attributed to factors such as increasing cases of atrial fibrillation globally, wide range of potential applications of microelectronic medical implants, increasing adoption of microelectronic medical implants, technological advances in microelectronic medical implants and growing global elderly population.
The market scope in this report is segmented into product type and applications. Based on product type, the report covers pacemakers, defibrillators, neurostimulators, hearing implants, ocular implants, and others. The market breakdown by applications includes cardiology, neurology, audiology, ophthalmology, and others.
Pacemakers will dominate the market for microelectronic medical implants.
The North American microelectronic medical implants market was valued at $23.5 billion in 2023 and estimated to be $45.8 billion in 2029, growing at a CAGR of 11.8% during the forecast period.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Consulting Editor’s Credentials

Melissa Dueck brings more than 25 years of health industry experience to the consulting analyst role with expertise in pharmaceuticals, medical technologies, and hospital operations. Ms. Dueck holds an MBA in Health Care Management, an MPH in Global Health, and is a pending doctoral candidate. She has authored several industry-specific documents and is a well-respected, trusted contributor to the market intelligence community. Her writings are published in magazines, newspapers, and professional journals. She is also an experienced custom market research writer who has worked with a large variety of clients in many fields who require innumerable variations to research documents. Ms. Dueck serves the health and medical community through emergency room medical training, healthcare information system coordination, program implementation and evaluations, and strategic business oversight planning.

Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Microelectronic Medical Implants: Products, Technologies & Opportunities130Free
Chapter- 1: Executive Summary4Free
Chapter- 2: Market Overview2Free
Chapter- 3: Market Dynamics8Free
Chapter- 4: Regulatory and Reimbursement Landscape8Free
Chapter- 5: Emerging Technologies 1Free
Chapter- 6: Market Segmentation Analysis62Free
Chapter- 7: Competitive Intelligence2Free
Chapter- 8: Sustainability in the Microelectronic Medical Implant Industry: An ESG Perspective4Free
Chapter- 9: Appendix39Free
Published - May-2016| Analyst - Andrew McWilliams| Code - HLC016E

Report Highlights

The global market for microelectronic medical implants should reach over $37.6 billion in 2021 from over $24.6 billion in 2016 at a compound annual growth rate (CAGR) of 8.8% from 2016 to 2021.

Report Includes

  • An overview of the global markets and technologies for microelectronic medical implants.
  • An analysis of global market trends, with data from 2015, 2016 and projections of compound annual growth rates (CAGRs) through 2021.
  • Major implant types and applications, both commercial and developmental.
  • Global market size and segmentation, including historical data on sales by application and implant type.
  • Market drivers and constraints.
  • A look at industry structure, competition and market shares.
  • Factors that may influence the long-term market for microelectronic implants.
  • Profiles of major players in the industry.
Published - May-2011| Analyst - Andrew McWilliams| Code - HLC016D

Report Highlights

The global market for microelectronic medical implants, accessories, and supplies was worth an estimated $15.4 billion in 2010. The market is projected to grow to $16.3 billion in 2011 and $24.8 billion in 2016, a compound annual growth rate (CAGR) of 8.8%, between 2011 and 2016. 

Published - Jun-2007| Analyst - Andrew McWilliams| Code - HLC016C

Report Highlights

  • The global market for microelectronic medical implants was worth an estimated $11.7 billion in 2006. The market is projected to grow to $12.6 billion in 2007 and $22.1 billion in 2012 at a CAGR of 11.9% from 2007 to 2012.
  • Cardiac implants were by far the largest market segment in 2006, accounting for more than three-quarters of total implant sales. Neurostimulators were the second largest market segment, with about 9% of the market, followed by accessories such as leads and electrodes, with a 7% market share. executive summary (Continued)
  • However, the market for neurostimulators is projected to grow over twice as fast as the market for cardiac implants from 2007 to 2012, that is, at a CAGR of 20% vs. 10% respectively.
Published - Sep-2004| Analyst - Andrew McWilliams| Code - HLC016B

Report Highlights

  • The global market for microelectronic medical implants is projected to be $11.9 billion in 2004 and to rise at an average annual growth rate (AAGR) of 22.1% to $32.3 billion in 2009.
  • Cardiac implants by far were the largest market segment in 2003, with sales of $7.2 billion, or more than three-quarters of total sales.
  • Neurostimulators were the second largest market segment, with sales of $944 million, but are projected to grow at an AAGR of 39.7%, more than double that of cardiac implants (18.4%).
  • The AAGR for accessories and supplies (27.5%) also is expected to outstrip growth of the market as a whole. The slowest-growing market segments likely will be spinal fusion stimulators and implantable drug pumps.
  • Eye implants are unlikely to see any commercial sales before 2009.

Related Reports

Medical Devices: Technologies and Global Markets

Published - Oct 2024 | Publisher - Partha Sarathi Das | Code - HLC170F

The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.

Infusion Pumps and Devices: Technologies and Global Markets

Published - Sep 2024 | Publisher - BCC Publishing | Code - HLC071E

The global market for infusion pumps is expected to grow from $10.1 billion in 2024 and is projected to reach $14.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.7% during the forecast period of 2024 to 2029.

Global Markets for Drug-Device Combinations

Published - Jul 2024 | Publisher - BCC Publishing | Code - PHM045F

The global market for drug-device combinations is expected to grow from $129.4 billion in 2024 and is projected to reach $199.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 9.1% during the forecast period of 2024 to 2029.

Global Markets and Technologies for Advanced Drug Delivery Systems

Published - Mar 2024 | Publisher - BCC Publishing | Code - PHM006N

The global market for advanced drug delivery systems is expected to increase from $262.6 billion in 2023 to $359.1 billion by the end of 2028, with a compound annual growth rate (CAGR) of 6.5% during the forecast period of 2023-2028.

Recent Reports

Conventional and Alternative Pain Treatment Markets

Published - Nov 2024 | Publisher - Partha Sarathi Das | Code - HLC266B

The global market for conventional and alternative pain treatment is expected to grow from $96.2 billion in 2024 and is projected to reach $144.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.

CRISPR Technology: Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC258C

The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.

Chronic Disease Management: Therapeutics, Device Technologies and Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC239C

The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.

Medical Devices: Technologies and Global Markets

Published - Oct 2024 | Publisher - Partha Sarathi Das | Code - HLC170F

The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.

Point-of-Care Diagnostics: Technologies and Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC043H

The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.

Top Trending Reports

Single-use Technologies for Biopharmaceuticals: Global Markets

Published - Nov 2024 | Publisher - BCC Publishing | Code - BIO099F

The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.

Cell and Gene Therapy Tools, and Reagents: Global Markets

Published - Nov 2024 | Publisher - BCC Publishing | Code - BIO208C

The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.

Global Market Opportunities and Competitive Landscape for CDMO

Published - Nov 2024 | Publisher - BCC Publishing | Code - PHM238B

The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.

Chronic Disease Management: Therapeutics, Device Technologies and Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC239C

The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.

CRISPR Technology: Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC258C

The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Microelectronic Medical Implants: Products, Technologies & Opportunities
Sample Report